229 related articles for article (PubMed ID: 26750097)
41. Optical coherence tomography findings in stage 4A retinopathy of prematurity: a theory for visual variability.
Joshi MM; Trese MT; Capone A
Ophthalmology; 2006 Apr; 113(4):657-60. PubMed ID: 16581425
[TBL] [Abstract][Full Text] [Related]
42. Diode laser photocoagulation posterior to the ridge in severe stage 3+ threshold retinopathy of prematurity.
Arvas S; Sarici AM; Akar S
Cutan Ocul Toxicol; 2014 Sep; 33(3):197-200. PubMed ID: 24147941
[TBL] [Abstract][Full Text] [Related]
43. Effect of macular edema in the premature period on refraction in infants screened and treated for retinopathy of prematurity.
Cengiz A; Kalayci M; Suren E; Cetinkaya E; Duman F; Erol MK
Photodiagnosis Photodyn Ther; 2021 Mar; 33():102133. PubMed ID: 33307233
[TBL] [Abstract][Full Text] [Related]
44. Prevalence of myopia at 9 months in infants with high-risk prethreshold retinopathy of prematurity.
Davitt BV; Dobson V; Good WV; Hardy RJ; Quinn GE; Siatkowski RM; Summers CG; Tung B;
Ophthalmology; 2005 Sep; 112(9):1564-8. PubMed ID: 16023214
[TBL] [Abstract][Full Text] [Related]
45. Macular edema in Asian Indian premature infants with retinopathy of prematurity: Impact on visual acuity and refractive status after 1-year.
Vinekar A; Mangalesh S; Jayadev C; Bauer N; Munusamy S; Kemmanu V; Kurian M; Mahendradas P; Avadhani K; Shetty B
Indian J Ophthalmol; 2015 May; 63(5):432-7. PubMed ID: 26139806
[TBL] [Abstract][Full Text] [Related]
46. [Analysis of choroidal thickness in AP-ROP, threshold disease and ROP without laser photocoagulation].
Gökgöz-Özisik G; Akkoyun I; Oto S; Bayar SA; Tarcan A; Kayhan Z; Yilmaz G
Ophthalmologe; 2016 Jan; 113(1):58-65. PubMed ID: 26142227
[TBL] [Abstract][Full Text] [Related]
47. Effect of gestational age at birth, sex, and race on foveal structure in children.
Jin J; Friess A; Hendricks D; Lehman S; Salvin J; Reid JE; Wang J
Graefes Arch Clin Exp Ophthalmol; 2021 Oct; 259(10):3137-3148. PubMed ID: 33961109
[TBL] [Abstract][Full Text] [Related]
48. Stratus optical coherence tomography findings in patients with retinopathy of prematurity.
Lago Ad; Matieli L; Gomes M; Baba NT; Farah ME; Belfort Junior R; Moraes NS
Arq Bras Oftalmol; 2007; 70(1):19-21. PubMed ID: 17505713
[TBL] [Abstract][Full Text] [Related]
49. Macular parameters and prematurity: A spectral domain coherence tomography study.
Tariq YM; Burlutsky G; Mitchell P
J AAPOS; 2012 Aug; 16(4):382-5. PubMed ID: 22824491
[TBL] [Abstract][Full Text] [Related]
50. One-year clinical outcome after laser treatment for retinopathy of prematurity at a tertiary center in Turkey.
Gunay M; Celik G; Ovali F; Yetik H; Aktas A; Gunay BO
Int Ophthalmol; 2015 Feb; 35(1):27-35. PubMed ID: 25381161
[TBL] [Abstract][Full Text] [Related]
51. Spectral domain optical coherence tomography evaluation of macular changes in Eales disease.
Goel N; Kumar V; Arora S; Jain P; Ghosh B
Indian J Ophthalmol; 2018 Mar; 66(3):433-438. PubMed ID: 29480258
[TBL] [Abstract][Full Text] [Related]
52. Foveal Depression and Related Factors in Patients with a History of Retinopathy of Prematurity.
Miki A; Honda S; Inoue Y; Yamada Y; Nakamura M
Ophthalmologica; 2018; 240(2):106-110. PubMed ID: 29742514
[TBL] [Abstract][Full Text] [Related]
53. Microstructural changes in the retina related to prematurity.
Pueyo V; González I; Altemir I; Pérez T; Gómez G; Prieto E; Oros D
Am J Ophthalmol; 2015 Apr; 159(4):797-802. PubMed ID: 25534498
[TBL] [Abstract][Full Text] [Related]
54. [Effects of intravitreal pegaptanib or bevacizumab and laser in treatment of threshold retinopathy of prematurity in zone I and posterior zone II--four years results].
Autrata R; Senková K; Holousová M; Krejcírová I; Dolezel Z; Borek I
Cesk Slov Oftalmol; 2012 Feb; 68(1):29-36. PubMed ID: 22679695
[TBL] [Abstract][Full Text] [Related]
55. Comparison of iridocorneal angle in infants with retinopathy of prematurity and healthy infants using spectral domain optical coherence tomography.
Cernichiaro-Espinosa LA; García-Huerta MM; Giordano VE; Salinas-Longoria SM; Romero-Vera R; García-Aguirre G; Salcedo-Villanueva G; Quiroz-Mercado H; Martinez-Castellanos MA
J AAPOS; 2014 Aug; 18(4):344-6. PubMed ID: 25173896
[TBL] [Abstract][Full Text] [Related]
56. Efficacy of intravitreal bevacizumab for zone-II retinopathy of prematurity.
Karkhaneh R; Khodabande A; Riazi-Eafahani M; Roohipoor R; Ghassemi F; Imani M; Dastjani Farahani A; Ebrahimi Adib N; Torabi H
Acta Ophthalmol; 2016 Sep; 94(6):e417-20. PubMed ID: 27009449
[TBL] [Abstract][Full Text] [Related]
57. Outcomes after Intravitreal Bevacizumab versus Laser Photocoagulation for Retinopathy of Prematurity: A 5-Year Retrospective Analysis.
Hwang CK; Hubbard GB; Hutchinson AK; Lambert SR
Ophthalmology; 2015 May; 122(5):1008-15. PubMed ID: 25687024
[TBL] [Abstract][Full Text] [Related]
58. Correlation between morphologic features on spectral-domain optical coherence tomography and angiographic leakage patterns in macular edema.
Brar M; Yuson R; Kozak I; Mojana F; Cheng L; Bartsch DU; Oster SF; Freeman WR
Retina; 2010 Mar; 30(3):383-9. PubMed ID: 20216291
[TBL] [Abstract][Full Text] [Related]
59. USE OF HAND-HELD OPTICAL COHERENCE TOMOGRAPHY DURING RETINOPATHY OF PREMATURITY SCREENING DEMONSTRATES AN INCREASED OUTER RETINA FROM EARLY POSTMENSTRUAL AGE IN PRETERM INFANTS WITH RETINOPATHY OF PREMATURITY.
Anwar S; Nath M; Patel A; Tyradellis S; Gottlob I; Proudlock FA
Retina; 2024 Feb; 44(2):306-315. PubMed ID: 37824817
[TBL] [Abstract][Full Text] [Related]
60. [The analysis of failure diode laser treatment of active phase of retinopathy of prematurity].
Gotz-Wieckowska A; Rydlewska-Fojut M; Siennicka A; Burchardt-Kroll E; Gadzinowski J
Klin Oczna; 2006; 108(1-3):39-42. PubMed ID: 16883938
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
